Abstract: Traditional Chinese medicines (TCMs), a key branch of natural medicines, play an important role in the treatment of diseases because of their reliable clinical performance. Identification of their active compounds constitutes a bottleneck in the development of TCMs. Screening and analysis of active compounds is a challenge in TCM research. This review summarizes recent progress in the development of biological fingerprinting strategies for screening and analyzing bioactive compounds in TCMs using molecular recognition, metabolism and omics tools. The evaluated strategies include the following techniques: microdialysis/centrifugal ultrafiltration-HPLC, biochromatography, metabolic fingerprinting analysis, 2-dimensional biochromatography and omics fingerprinting analysis.
INTRODUCTION
Traditional Chinese medicines (TCMs) have a long history of development as therapeutic agents for a range of diseases. They have undergone nearly five thousand years of clinical practice, from the earliest records of the Shang Oracle, and form a complete theoretical system with extremely wide application in China [1] . As a branch of traditional medicine, TCMs play an important clinical role and can be complementary to other modern medicines. According to a survey performed in 1995, there have been 12, 807 Chinese medicinal resources in China, including 11, 146 medicinal plants, 1581 medicinal animals and 80 medicinal minerals [2] . Although TCMs are the most abundant source of natural medicine in the world, many basic theories and key scientific issues pertaining to TCMs remain questionable [3] . Compared with Western medicines (synthetic drugs), TCMs demonstrate unique advantages in the treatment of human diseases, such as viral infection, cardio-cerebral vascular diseases, endocrine system diseases and age-related diseases. In addition, synthetic drugs face challenges such as high cost, long development time, sideeffects and drug-induced diseases [4] . The Chinese pharmaceutical industry does not have sufficiently large medicinal compound libraries or established research and development of new medicines [3, 5] . Therefore, the development and modernization of TCMs, combined with modern scientific thought and means, is an important strategy for drug development [6] . Exploration and application of TCMs have achieved considerable progress by combining modern techniques in medicine, biotechnology *Address correspondence to this author at the Key Laboratory of Offshore Marine Environment Research of Liaoning Higher Education, Dalian Ocean University, Dalian, 116023, China; Tel/Fax: +86-411-84763520; E-mail: liangkong@dlou.edu.cn and chemistry since the Chinese government explicitly proposed the modernization of TCMs in 1997. These efforts have focused on separation and screening of the active ingredients in TCMs, quality control, authentic identification of medicinal materials, qualitative and quantitative analyses of the chemical composition of the compounds and pharmacological research [7] [8] [9] .
The modernization of TCMs has been explored for more than ten years in terms of the characteristics of multicomponent and multi-target TCMs. This research has focused on the following areas. (1) Analysis of complex systems of TCMs. TCM prescription and pharmacological action in the human body is complex. Therefore, the study of TCM components has been carried out under the guidance of complex and systemic scientific theories or methods, such as systems biology and multidimensional analysis [10] [11] [12] [13] . (2) Key technologies for separation of active ingredients from TCMs. Identification of the active components of TCMs and creation of modern Chinese medicines are not possible by means of routine methods; novel methods for the characterization of TCMs are required. Identification of the active ingredients in TCMs is not a simple task [11, 14] . (3) Scientific interpretation of the pharmacology and mechanisms of action of the active ingredients. Despite enormous scientific efforts made toward the modernization of TCMs, the study of TCMs still faces many problems and difficulties, and the identification of active constituents is a bottleneck for the development of TCMs. Wang and Zhang proposed that the main hindrances to developing TCMs are the screening and identification of bioactive substances and establishment of TCM pharmacology [11, 13, [15] [16] [17] .
Screening and analyzing bioactive components has always been a challenge in the research of natural medicines, such as TCMs. Many methods and technologies have been used in the screening and analysis of bioactive components from TCMs to date. In TCM screening, the classic wholeanimal model remains an important screening tool [18] . The advantages of the whole-animal model for TCM screening are that the therapeutic effect, adverse reactions and toxicity of drugs can be investigated. However, it has significant limitations because of the large number of whole animals required, low efficiency and high cost. Therefore, the wholeanimal model is not suitable for large-scale rapid screening, which has slowed the development of TCM screening [19] . To overcome these deficiencies, a tissue and organ screening model, cellular screening model and molecular screening model have been developed. These models have high efficiency, high throughput and small sample requirements.
The tissue and organ screening model has achieved some success in the screening of bioactive compounds from TCMs in combination with technologies from other fields, such as morphology, biochemistry, and electronics. In cardiovascular medicine screening, Zhang et al. established the isolatedperfused mouse heart model according to Langendorff's for screening injected TCMs by monitoring cardiac function and coronary flow in vitro [20] . Zhang et al. demonstrated that bioactive compounds isolated from TCMs possess unique "dual effects" that are beneficial in treating hypertension in rats' thoracic aortas [21] . The multitude of uncertain factors involved in this model affect the accuracy of the results and limit its application in the screening of TCMs [22] . However, the method is highly valuable for in-depth screening and validation of active compounds.
The relative ease of obtaining a variety of cells, including disease-related cells, and the high-throughput characteristic of the cellular screening model have made it the main approach for screening and evaluating active compounds in TCMs. In vitro cytotoxic activity tests are generally adopted in screening for antitumor compounds in TCMs. For example, Ho et al. used Vero cells (African green monkey kidney cells) inoculated with hepatitis C virus (HCV) as a model for screening hepatitis C virus inhibitors from 19 TCMs [23] . The model is coupled with observation of cell physiology to identify active compounds. The model can indicate the combined effect on biological processes, but it cannot identify specific molecular pathways and targets affected by the drug.
With the development of molecular pharmacology, new drug targets, such as receptors, enzymes and genes, have been discovered. These new targets provide new information and opportunities for the molecular screening model [24, 25] . Studies have shown that the bioactivity generated by Chinese and Western medicine is similar in that it results from the interaction between bioactive compounds and biomolecules. Many new technologies and methods concerning the molecular screening model have been adopted for the screening and analysis of TCMs. Since 1980, Wang et al. has used 11 types of receptors and enzymes for high-throughput screening (HTS). Alantolactone, medicarpin and other bioactive compounds were screened from more than 400 kinds of extracts from 150 TCMs [26] [27] [28] . The technology demonstrated high efficiency, high activity, high speed and specificity. However, the application of HTS for TCMs is not satisfactory, especially in the areas of natural drug screening [29] . HTS may yield false positives or false negatives based on a single target because of a lack of consideration of multi-component, multi-target and holistic approaches during screening [30, 31] . Biochromatography (BC) can partially overcome these disadvantages. BC involves special affinity chromatography with matrix-mobile interacting systems to study the mechanisms of biological interactions between bioactive compounds and biological molecules [32] . Biological fingerprinting analysis (BFA) is based upon BC. BFA may allow for the screening of bioactive compounds in TCMs [33] .
In the drug discovery industry, the pharmacological effects and activities of Western medicines are related to their ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) properties in vivo in addition to interaction with their targets. ADME properties are crucial determinants of the ultimate clinical success of a drug. The early introduction of ADMET screening has been realized during the drug discovery process [31, 34] . Some studies have shown that TCMs are similar to Western medicines, and TCM activity has also been related to ADMET properties. Studies of ADMET properties of TCMs have been developed and applied to the screening of natural medicines [35, 36] .
SCREENING AND ANALYSIS OF BIOACTIVE COMPONENTS IN TCMS BY BFA BASED ON MOLE-CULAR RECOGNITION
As a high performance separation technology, chromatography and its hyphenated techniques have been used for the analysis of complex samples. However, conventional chromatographic techniques, including HPLC/MS, GC/MS or 2D-HPLC/GC, cannot provide information on the biological interactions between compounds in TCMs and biological molecules, while BFA based on molecular recognition can combine chromatographic separation with a drug interaction assay and permit discrimination of bioactive component peaks from numerous other chromatographic peaks [33, 37, 38] . In general, there are two strategies for TCM screening and analysis by BFA. In the first strategy, interactions between the crude extracts and the target are determined prior to chromatographic analysis. Biological fingerprinting chromatograms can be obtained by comparison of chromatograms of the sample before and after being treated with the target. In the second strategy, the biomolecular target is immobilized as the stationary phase of the liquid chromatographic column, and the chromatogram indicates the interaction between the compounds in TCMs and the target in the column. The binding of drugs to plasma proteins has a significant impact on the transport of drugs and their metabolites, regulating drug activity and mediating side-effects. It is well known that most drugs can bind to plasma proteins and that the binding process is quantitatively reversible. Drug and plasma protein complexes can not only serve as a depositary for the circulation of drugs, but they can also reduce the potency of drugs and increase the duration of their action [39] [40] [41] . Human serum albumin (HSA) and 1 -acid glycoprotein ( 1 -AGP) are the most important plasma proteins [40, 42, 43] . Microdialysis sampling coupled with HPLC allows for determination of the concentrations of unbound drugs after sampling by a tubular dialysis membrane from the drug-protein solution, and unlike biochromatography, it can determine comprehensive information about the interactions between TCM components with multiple plasma proteins in solution. This method also has the advantage that it is easy to be hyphenated on-line with analytical techniques. Therefore, it can be used in for separation, identification and screening of bioactive molecules of TCMs by molecular recognition of components in TCMs and plasma protein. Guo et al. used microdialysis coupled with HPLC to study the interactions between bioactive components in Rhizoma Chuanxiong and proteins. In this study, microdialysis recoveries and binding degrees of compounds in Rhizoma Chuanxiong with HSA and human plasma proteins were determined by biological fingerprinting chromatograms. The binding characteristics of 13 bioactive components to HSA and human blood serum were observed from the chromatograms: three bioactive compounds were identified as ferulic acid, senkyunolide A and 3-butylphthalide. The results also showed that most of the compounds in Rhizoma Chuanxiong bound to human blood serum more extensively than to HSA [44] . Microdialysis coupled with HPLC was used to study the interaction between Taxus extract and HSA. Fig. (1) illustrates the 12 bioactive components that were screened; five of them were identified and are listed in Table 1 . Some preliminary results show that Taxane binding sites are mainly located in site I and II of HSA. The interaction between Taxus and human blood serum was further investigated. It can be seen that this method can be effectively used for the screening and study of biological interactions of TCM bioactive components with proteins.
Screening and Analysis of Bioactive Compounds with DNA
Some diseases are caused by genetic mutations that affect cell structure or metabolism, such as in sickle-cell anemia, tumors, viral hepatitis and AIDS. In view of this finding, genetic fragments can be used as drug targets for drug discovery. The DNA target for drug screening was rapidly following the first published study in 1983 [45] . BFA was also applied in screening for DNA-binding agents in TCMs. Su et al. developed a microdialysis sampling method combined with HPLC to study DNA-binding components in the TCM extracts: Coptis chinensis Franch, Phellodendron amurense Rupr. and Sophora flavescens Ait. The BFA chromatograms had high selectivity for binding to calf thymus DNA (ct-DNA). Some bioactive compounds, alkaloid analogs, were screened by evaluating their interaction with ct-DNA. Their association constants (K) to ct-DNA and competitive binding behaviors were determined by microdialysis/HPLC [33] , and multiple bioactive components that interacted with DNA could be simultaneously analyzed. The feasibility of this method for screening and analysis of bioactive compounds in TCMs was verified. In the following years, BFA based on centrifugal ultrafiltration (CUF) sampling combined with HPLC was proposed and compared to sampling by CUF with microdialysis [46] . The recoveries by CUF are much higher than those by microdialysis. In addition, CUF is timesaving because centrifugation of batch samples can be performed simultaneously. BFA based on CFU-HPLC was also applied to screening and analysis of the natural products Coptis chinensis Franch and Rheum palmatum (L.). From the obtained biological fingerprinting chromatograms, seven active compounds in C. chinensis Franch and 11 in Rheum palmatum (L.) were screened and identified [46] . On the basis of the microdialysis/CUF-HPLC method, BFA was shown to be effective for screening of bioactive compounds and studying the complex interactions of a single DNA target with multiple components in a TCM.
Screening and Analysis of Bioactive Compounds that Interact with Tubulin
In general, tumor cells and multidrug-resistant tumor cells are used as targets in antineoplastic drug screening. Microtubules are central to a number of cellular processes including the formation of the mitotic spindle, which is composed of a backbone of tubulin dimers [47] . The importance of the mitotic spindle in mitosis and cell division makes microtubules an important target for anticancer drugs [48] [49] [50] . Tubulin has been widely used in screening of anticancer drugs from TCMs.
A convenient microdialysis-HPLC assay for screening antimicrotubule compounds was used to monitor the binding of compounds extracted from TCMs of Taxus cuspidata Siebold & Zucc (Taxus) [51] . The biological fingerprinting chromatograms ( Fig. 2) indicated that at least five compounds in the Taxus extract interacted with microtubule proteins. These compounds were identified as the taxoids of taxol, baccatin III, 10-deacetylbaccatin III (10-DAB), cephalomannine and 7-epi-10-deacetyltaxol (7-epi-10-DAT). The assembly-promoting and disassembly-inhibiting activities of those compounds were evaluated. The influencing factors and competitive binding behavior of five bioactive compounds with microtubules was also investigated.
Screening and Analysis of Bioactive Compounds Based on the Protein Functions in Tumor Cells
Identification of the pharmacological pathways of bioactive components is complex. Cellular screening is an effective method of screening for active compounds that reverse physiological processes, such as multidrug resistance in chemotherapy. It is usually performed by observing apparent physiological phenomena in cells. The generation of multidrug resistance of tumor cells has become the main reason for cancer chemotherapy failure [52, 53] . Lei et al. proposed a BFA method involving microdialysis-HPLC-MS with multidrug resistant MCF-7 cell systems. The results indicated that pseudolaric acid A (PAA) and pseudolaric acid B (PAB) in the extract of Cortex Pseudolarix and tetrandrine (TET) in the extract of Radix Stephaniae interact with breast cancer MCF-7 cells, and TET showed higher binding activity in the reversal of multidrug resistance. It could be concluded that the active compounds may specifically bind the P-gp sites of cancer cells [54] . This approach, which was based on evaluating the interactions of active components and tumor-specific proteins of tumor cells, is efficient, but the speed of screening and analysis cannot meet the requirements of high throughput because of the required preparation of multidrug resistant cell systems.
Screening and Analysis of Bioactive Compounds by Biochromatography
HPLC is usually considered as a tool for the separation of chemical compounds. This viewpoint ignores the mechanisms of the chromatographic process, which are based on the interactions between the solute and stationary phase. In fact, HPLC can be used as a probe for intermolecular interactions. A variety of biopolymers, including proteins, DNA, lipids and receptors, can be immobilized on the chromatographic matrix and used to probe biomacromolecule-drug interactions. The methodology of biochromatography was developed with the HPLC stationary phase and immobilized biomacromolecules [32, 55] . When biochromatography is performed, chromatographic retention provides information regarding the interaction (e.g., degree of binding). Since the biological activity of a compound is defined by its interaction with a biomacromolecule, the approach can be used to identify the pharmaco- logical activity and toxicity of compounds. This concept was recently incorporated into the BFA of TCMs.
Screening and Analysis of Bioactive Compounds by Immobilized Liposome Chromatography (ILC)
The absorption of drugs mainly depends on the permeability of cell membranes and plays an important role in the ADMET properties of compounds. Thus, the permeability of biological membranes to drugs has been considered a key factor in the evaluation of their bioactivity [56] [57] [58] . The cell membranes are composed of liposomes formed by phosphatidylcholine. Phosphatidylcholine can mimic the lipid bilayer structure and the fluidity of biological membranes. Mao et al. prepared the immobilized liposome chromatography (ILC) stationary phase using phosphatidylcholine and introduced the ILC as a tool for the screening and analysis of a TCM extract. More than ten components from a Radix Angelica Sinensis extract were significantly retained on an ILC column, and three of them were identified. In this study, the chromatographic conditions of ILC-pH, column temperature and ionic strength -were investigated. It was found that the separation selectivity of ILC is strongly affected by the eluent pH and only slightly by the column temperature and ionic strength [59] . In addition, ILC of unilamellar liposomes covalently coupled on silica gel was also developed [60] . Sheng et al. utilized this technique to separate and screen potential bioactive compounds in Danggui Buxue decoction. More than ten components, including bioactive ingredients Ligustilide, astragaloside IV and formononetin, were significantly retained on ILC columns [61] .
To validate BFA using ILC, the correlation of the results obtained with ILC and the rat-intestine model was investigated using Danggui Buxue decoction. A good correlation between the retentive components of bioactive compounds on ILC and the rat-intestine absorption percentage was obtained with a correlation coefficient r =0.9356 [62] . It was concluded that the absorption of drugs was passive transcellular, and that ILC could be used to simulate the biomembrane penetration of drugs by the passive transcellular mode in vitro.
At the same time, another important type of biomembrane chromatography, cell membrane chromatography (CMC), was developed by He et al. They immobilized living biological cell membranes on silica supports [63] [64] [65] . The cell membrane was expanded from blood cells to pancreatic -cells, endothelial cells, peritoneal macrophage cells, vascular smooth muscle cells, myocardium cells and so on [66] [67] [68] [69] [70] . CMC was found to have the characteristics of both cell membrane activity and chromatographic separation. It can be used in a preliminarily evaluation of drug-receptor affinities for drug candidates. A good correlation was observed between the retention and the binding affinity to the receptor in cell membranes [70] [71] [72] . The technique was applied to studies of the bioactive components in the following TCM extracts: Angelica sinensis (Oliv.) Diets, Ligusticum chuanxiong, Salvia miltiorrhiza Bunge and Atractylodes macrocephala koidz [67, 68, [72] [73] [74] [75] [76] . More than ten bioactive components in TCMs were screened and analyzed. All of the results showed that the retention values of the components on the CMC column were largely consistent with the observed pharmacological activities in vitro.
The performance of CMC is less stable than ILC in that biological activities of cell membranes in CMC weaken with time. The application of ILC and CMC is also limited in 
Screening and Analysis of Bioactive Compounds by Immobilized Plasma Protein Chromatography
Although BFA of TCMs based on the binding between drugs and plasma proteins can be determined by microdialysis/CUF-HPLC, the biopolymers are not stable during the analysis cycles and result in experimental error. Studies show that immobilized biopolymer chromatography can eliminate the problems. The retention of a solute by immobilized biopolymer chromatography is clearly related to the solute's binding affinity for the free protein, and the relationship appears to be quantitative [55] . Moreover, immobilized biopolymer chromatography can be used as a rapid and accurate probe of drug-protein binding without the pretreatment step of microdialysis/CUF. In 1999, Wang et al. introduced this strategy for screening and analysis of the biologically active components in Angelica sinensis (Oliv.) Diels with immobilized HSA chromatography. Ten active peaks were separated from the methanol extract of Angelica sinensis. Two principal peaks were identified as ferulic acid and ligustilide, which are the principal biological active components of Angelica sinensis (Oliv.) Diels [79] . The results showed that HSA biochromatography is an effective and fast way of analyzing and screening bioactive components in TCMs. In other studies, Wang et al. obtained more than five bioactive components from Artemisia capillaries Thunb by immobilized HSA chromatography that have been used to treat hepatitis A. Two of them were identified as scoparone (SCO, 6, 7-dimethoxycoumarin) and capillarisin (CAP) [80] . More than ten components were obtained from the Radix Salviae Miltiorrhizae and YiXinTongMei extracts for the treatment of heart disease by another immobilized 1 -AGP chromatography approach. Tanshinone IIA was identified as an active component in this extract [81] . Quality control of bioactive components is very important for natural medicines. Biochromatography can be used to analyze bioactive components in TCMs because of its selectivity for these components. Kong et al. resolved the aqueous extracts of four single TCMs using HSA chromatography. As shown in Fig. (3) , four major active components can be detected in the chromatograms of Angelica sinensis (Oliv.) Diels and Radix astragal, respectively. Two major active components in Paeonia lactiflora Pall and three major active components in Rhizoma Chuanxiong were separated. Thirteen bioactive components were screened and two of them were identified. Their concentrations in the TCMs were determined by HSA biochromatography [82] . It was further shown that biochromatography is an effective and fast method for analysis and screening of bioactive compounds in TCMs.
Screening and Analysis of Bioactive Compounds by Immobilized DNA Chromatography
Su et al. developed an immobilized DNA stationary phase on silica for the screening and analysis of bioactive components in TCM extracts [46] . In this work, genomic DNA was bound to the surface of amino silica through the formation of a phosphoramidate bond between the 5' terminal phosphate group and the amino silica group. The properties of the immobilized DNA stationary phase were investigated, such as the effect of the ionic strength and concentrations of Mg 2+ , EDTA and CH 3 CN in the mobile phase on retention. The BFAs of the Coptis chinensis Franch and Rheum palmatum L. extracts were performed by immobilized DNA chromatography. One of the biological fingerprinting chromatograms is shown in Fig. (4) . It was found that 7 compounds in Coptis chinensis Franch, including berberine, palmatine and jatrorrhizine, and 14 compounds in Rheum palmatum L., including aloe-emodin, rhein, emodin, chrysophannol-8-O-glucophranoside and physionl-8-O-glucophranoside, bound to the immobilized DNA [46, 83] .
The results of BFA with biochromatography using immobilized DNA stationary phases showed that this type of biochromatography is an effective method for screening and analyzing multiple DNA binding active compounds in complex samples.
SCREENING AND ANALYSIS OF BIOACTIVE COMPONENTS IN TCMS BY BFA BASED ON METABOLISM
In drug discovery, accurate pharmacokinetic and metabolic data must be available to support in vitro biological screening because good activity in vitro cannot be extrapolated to good activity in vivo unless a drug has good bioavailability and a desirable duration of action [84] [85] [86] [87] . Approximately 39% of drug candidates are dropped because their activities decreased due to biological transformation in the body [88] . A growing awareness of the key roles that pharmacokinetics and drug metabolism play as determinants of in vivo drug action has led to the use of drug metabolism properties as part of their screening processes. In 1987, serum pharmacology of TCMs was introduced for TCM screening; the strategy is similar to the pharmacological processing of drugs in the body. Iwama et al. successfully explained why activities of Shassaikoto decoction are different in vivo and in vitro by analysis of the serum pharmacology of TCM [89] . Homma et al. proposed that the pharmacological activities would be apparent when the active compounds appeared in blood and urine with appropriate concentrations after administration. They established a pharmacokinetics screening strategy based upon this proposition. From 1992 to 1998, Homma et al. studied the TCM Saiboku-To for the treatment of bronchial asthma. Urine samples collected before and after the administration of Saiboku-To to healthy and asthmatic subjects were analyzed by nuclear magnetic resonance (NMR), mass spectrometry (MS), UV-spectra and HPLC. The bioactive compounds identified by this approach were magnolol and 8, 9-dihydroxydihydromagnolol stemming from M. officinalis, medicarpin and liquiritigenin from Glycyrrhiza glabra, baicalein, wogonin and oroxylin A from Scutellaria baicalensis and davidigenin of an unknown origin. To a certain extent, the pharmacological mystery of Saiboku-To was disclosed by resolving the pharmacokinetics and pharmacodynamics of these urinary products [90] [91] [92] [93] [94] . In China, Yang et al. adopted the serum pharmacological method for evaluation of the effect of the Suiqing pill on endothelial proliferation. The results indicated that the activity of a high dose of the drug was 20% higher than that of a low dose of the drug [95] . Although serum pharmacology provides a new strategy for screening and analysis of bioactive components in TCMs, some limitations have been found. (1) The preparation of drug-containing serum or urine is relatively time-consuming after oral administration of TCMs to animals or humans. (2) The amount of oral medication cannot be continually increased, thus the trace components in TCMs or metabolites cannot be detected and result in the loss of low concentrations of active compounds during the screening process. (3) There are individual differences in drug-containing sera that may complicate observation of the actual effects of the drugs in serum. Yao proposed a new strategy in which the bioactive compounds that have an effect on the target after metabolism in the body are studied [96] . According to the strategy, Kong et al. established a metabolic screening method in vitro for complex active compounds in TCMs [97] . A biological fingerprinting chromatogram of metabolism can be obtained by comparing the chromatograms for the crude extract before and after metabolism in vitro using a rat liver homogenate. With this method, the metabolite of coniferyl ferulate from Rhizoma Chuanxiong, ferulic acid ethyl ester and ligustilide were identified by HPLC-MS, UV-Vis spectroscopy and Infra-red spectroscopy. In addition, the antineoplastic activity of coniferyl ferulate and ferulic acid ethyl ester was detected by the MTT assay. The inhibition rate of coniferyl ferulate on HeLa cells was over 80% at a concentration of 5.4 ng/μl. However, its metabolite, ferulic acid ethyl ester, did not show any antineoplastic activity [97] . This study validated the feasibility of a metabolic screening method for active compounds in TCMs.
The method was further improved by adopting rat liver microsomes for BFA by microdialysis coupled with HPLC-MS, and the extract of Taxus cuspidate was analyzed by metabolic BFA. Five bioactive compounds and their metabolites were screened and identified.
Biological fingerprinting methods have been established for the screening and analysis of TCMs based on molecular recognition and metabolism in vitro. These methods can be used to evaluate the interactions between bioactive compounds and their targets and their ADMET processes in vitro. They have become efficient and useful strategies suited to characterizing TCMs. Some of the results of the cited studies and BFA applications are summarized in Table  2 .
Over the last few decades, significant progress has been achieved in BFA based on molecular recognition and metabolism. However, lack of clear targets and pharmacology of TCMs and the low resolution of BFA have limited further development of screening and analysis of bioactive components in TCMs. Hence many new technologies and methods have been developed to improve BFA, including two-dimensional biochromatography and omics approach. BFA of TCMs is approaching a new stage of development.
SCREENING AND ANALYSIS OF BIOACTIVE COMPOUNDS BY 2-D BIOCHROMATOGRAPHY
The application of biochromatography is often limited by its shortcomings of low column efficiency, long analysis time and poor compatibility with MS instruments. Therefore, the separation and analysis of complex components in TCMs becomes extremely difficult using biochromatographic systems. Multidimensional separation techniques provide ideal peak capacity and resolution [98] . Comprehensive 2-D chromatography has been widely used to characterize and separate complex mixtures due to its high peak capacity, powerful separation and high resolution [99] [100] [101] [102] . On the basis of 2-D separation, Chen and Hu et al. established a comprehensive 2-D liquid chromatographic separation system for TCM analysis [103] [104] [105] [106] . Furthermore, 2-D liquid chromatography with biochromatography and conventional HPLC was established to improve the peak capacity and resolution of BFA. In addition, the comprehensive 2-D system can provide maximum information with minimal amounts of material and allows for rigorous quantitative interpretation of the results.
Chen et al. developed a comprehensive 2-D biochromatography system for the analysis of components in Ginkgo biloba. Under optimal conditions, the 2-D system, which was based on a combination of an ILC column and an ODS column, resolved more than 41 components from a methanol extract of Ginkgo biloba. Thirteen of the components were preliminarily identified [107] . Su et al. [83] . As the components in TCM prescriptions are generally more complex than that in single TCMs, 2-D biochromatography is more suitable for analysis of TCM prescriptions. Wang et al. introduced 2-D biochromatography for the screening and analysis of bioactive components in the Longdan Xiegan Decoction (LXD). More than 100 compounds in LXD that interacted with the immobilized HSA were screened and analyzed by a comprehensive 2-D biochromatography method using an HSA column and an RP-HPLC column. Among them, 19 compounds were identified. More than 50 components in LXD were resolved using comprehensive 2-D biochromatography with an ILC column in conjunction with an RP column. Eight flavonoids and two iridoids were found to interact with the ILC column [108, 109] . The results showed that the comprehensive 2-D biochromatography system is capable of BFA of natural products in complex samples such as extracts of TCMs and their prescriptions.
SCREENING AND ANALYSIS OF BIOACTIVE COMPONENTS IN TCMS BY SYSTEMS BIOLOGY APPROACHES
Systems biology studies can provide an early indication that biological processes are driven together by systems of biology, genetics and chemistry in vivo, including genes, proteins, protein interactions, informational networks, cells, tissues or networks of cells, the organism and informational pathway responses. Thus, systems biology usually involves the study of biological systems by systematically perturbing them biologically, genetically or chemically [110, 111] . It has holistic, dynamic, hierarchical and integrated features. The primary feature is holistic, which is consistent with the characteristics of TCMs [112] . The bioactive components in TCMs are usually used, in essence, to treat living systems by adjusting their biological processes. Molecules of TCMs also participate in these biological processes. Therefore, systems biology provides an effective theoretical basis and methodology for screening and analyzing TCMs. It is feasible to use systems biology approaches for screening active compounds of TCMs and investigating their pharmacology. A systems biology technology platform is integrated by a variety of omics platforms, such as genomics, proteomics, metabolomics, chemical proteomics and transcriptomics. BFA coupled with omics technologies will greatly accelerate the bioactive component discovery process in TCMs. BFA coupled with omics technologies for screening and analyzing bioactive components in TCMs explores the mechanisms involved in the activities of the bioactive components.
Screening and Analysis of Bioactive Compounds by BFA Coupled with Proteomics
The pharmacological effects of natural medicines are often generated by alterations in the metabolism of material and energy [113] . Changes in the endogenous substance composition can be characterized by the use of analytical chemistry and an omics approach. In this method, changes in the composition of proteins or other cellular components can be observed on fingerprinting chromatograms of samples from a model animal after treatment with a TCM extract. In our ongoing study, after treatment with a TCM prescription of Tongguanwan, SD rats were killed and their livers rapidly removed, washed, minced and homogenized. Samples of liver were digested by a series of treatments with trypsin. Proteomic analysis was performed on a capillary LC-ESI MS/MS. The MS spectra for a sample of rat liver are shown in Fig. (5) ; it can be clearly seen that the two spectra are different. In addition, the species composition of protein was obviously changed after the rat was treated with the TCM prescription. It was concluded that proteomics can be used as a fast, effective method to identify changes resulting from biological effects caused by TCMs. Further analysis and identification of biomarkers associated with the bioactive component by an omics approach will help to reveal the pharmacological mechanisms and targets of TCMs. The above-mentioned studies showed that the proteomics approach is a valuable method for studying the bioactivity and targets of bioactive components because it can evaluate changes in protein composition that result from the biological effects of TCMs. The current study improves upon the understanding of TCM pharmacology and provides good prospects for the application of proteomics approaches in the screening and analysis of TCMs.
Screening and Analysis of Interacting Proteins by BFA Coupled with Chemical Proteomics
The pharmacological mechanisms of TCMs and TCM prescriptions are not entirely clear, with the exception of their clinical properties, such as the active ingredients, targets, interaction sites of the active ingredients. Although the BFA approach based on molecular recognition and metabolism has been widely used as a rapid, effective platform for the screening and analysis of bioactive components in TCMs, it is relatively limited in its ability to determine pharmacological mechanisms due to a lack of unambiguous targets and pharmacological pathways. At the same time, the choice of targets has become a potential bottleneck for Western medicines [115] . Thus, active components used as probes for target protein screening is vital, while the interaction between small molecules and proteins is the focus of chemical proteomics research. On the one hand, chemical proteomics can use small molecules as bait to fish out interacting proteins and identify new drug targets for different diseases. It has been a powerful method by which to investigate interacting proteomes [116] . On the other hand, it can be used for the rapid determination of pharmacological mechanisms.
Wang et al. successfully identified target proteins from rats by combining comprehensive 2-D biochromatography and a chemical proteomics approach. In their first work, Wang et al. screened and analyzed the bioactive components from Rhizoma corydalis by a comprehensive 2-D biochromatography method using a silica-bonded HSA column as the first dimension and a monolithic ODS column as the second. More than 100 compounds were screened, 13 of which were identified [117] . One of the bioactive compounds, l-THP, was submitted to target protein screening. This study investigated the mechanisms of the antinociceptive action induced by l-THP in the formalin test by combining comparative and chemical proteomics. The antinociceptive effect of l-THP was observed in the first and second phases of the formalin test. The combined comparative and chemical proteomics approaches were applied to indicate the mechanisms by which l-THP inhibits formalin-induced nociception in rats. The deregulated proteins involved in the response of l-THP treatment were evaluated in formalin-induced pain in rats. Thousands of proteins were identified, 17 of which survived their stringent filter criteria. Two proteins (Neurabin-1 and Calciumdependent secretion activator 1) were randomly selected and their expression levels were confirmed by Western blots analysis. The results matched well with the proteomic results. The immobilized l-THP beads used for binding to the targets were also developed in their study. The proteome that interacted with the immobilized l-THP was identified after incubation with cellular lysates [118] . They conclude that chemical proteomics will improve the understanding of mechanisms of pharmacology and provide an effective approach for target protein screening of TCMs. (91) cell (429) extracellular matrix (5) extracellular region (68) organelle (334) protein complex (97) Molecular_function (534) Molecular_function (559) antioxidant activity (10) binding (263) catalytic activity (330) enzyme regulator activity (9) motor activity (7) signal transducer activity (20) structural molecular activity (53) transcription regulator activity (8) translation regulator activity (8) transporter activity (71) antioxidant activity (10) binding (274) catalytic activity (344) chaperone regulator activity (1) enzyme regulator activity (11) motor activity (12) signal transducer activity (26) structural molecular activity (52) transcription regulator activity (8) translation regulator activity (7) transporter activity (67) Fig. (5) . The LC-MS profile of protein digests for a sample of rat liver before (A) and after (B) treatment with the TCM prescription of Tongguanwan extract. (C) and (D) are the species compositions of protein in rat liver before and after treatment, respectively.
CONCLUSIONS
The identification of active components is a bottleneck for the development of natural medicines such as TCMs. Furthermore, the pharmacological mechanisms of TCM prescriptions are still not clear, including their ADMET properties and synergetic effects of the active ingredients, targets, interaction sites of the active ingredients. It is necessary to establish a series of new screening and analysis methods and pharmacological models for the study of TCMs. BFA has been developed and utilized for screening and analysis of bioactive components in TCMs because it is well suited to the characteristics of TCMs, such as their multi-component, holistic adjustment and multi-target features. In addition, BFA can be used to simulate and evaluate the actions of drugs in vivo during screening and analysis of bioactive compounds. It can achieve the purpose of evaluating pharmacological parameters of various components of TCMs, screening and analysis of active ingredients and metabolites and the discovery of pharmacological pathways.
